Assura PLC Scrip Dividend Declaration (2375C)
10 October 2022 - 5:00PM
UK Regulatory
TIDMAGR
RNS Number : 2375C
Assura PLC
10 October 2022
10 October 2022
Assura plc
Scrip Dividend Declaration
Assura plc ("Assura" or "the Company"), the UK's leading primary
care property investor and developer, today announces that,
pursuant to its Scrip Dividend Scheme and in response to the scrip
dividend alternative for the quarterly interim dividend payable on
12 October 2022 (the "Scrip Dividend Alternative"), elections were
received in respect of 0.2 per cent. of the Company's ordinary
shares in issue as at the record date of 9 October 2022.
Electing shareholders will receive ordinary shares in the
Company ("Shares") in lieu of cash in respect of this dividend and,
accordingly 52,001 Shares (the "New Shares") will be issued by the
Company to such shareholders.
Application has therefore been made for the admission of the New
Shares to the Official List of the Financial Conduct Authority and
to trading on the London Stock Exchange's market for listed
securities ("Admission"). The New Shares will rank pari passu with
the Company's existing ordinary shares and Admission is expected to
occur at 8.00am on 12 October 2022.
Following the allotment of the New Shares, it is expected that
the total number of shares in issue will be 2,959,250,709 (none of
which will be held in treasury) and that, accordingly, the total
number of voting rights of the Company will be 2,959,250,709.
Copies of the documents relating to the Scrip Dividend
Alternative are available for inspection through the National
Storage Mechanism (
https://data.fca.org.uk/#/nsm/nationalstoragemechanism ).
This interim dividend is 100% Property Income Distribution
("PID").
Forms to register for gross PIDs (on future interim dividends)
are available on the Company's website. Please click here for PID
Forms .
- ENDS -
For more information, please contact:
Assura plc Tel: 01925 945354
Orla Ball, Company Secretary E mail: Investor@assura.co.uk
David Purcell, Investor Relations
Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Warrington, UK - caring for more than 600 primary
healthcare buildings, from which almost seven million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31
March 2022, Assura's portfolio was valued at GBP2,752 million.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
Assura plc LEI code: 21380026T19N2Y52XF72
*EPRA is a registered trademark of the European Public Real
Estate Association.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DIVBUBDGRSGDGDR
(END) Dow Jones Newswires
October 10, 2022 02:00 ET (06:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2023 to Apr 2024
